These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3549727)

  • 21. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.
    Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Miltiadous G; Goudevenos JA; Cariolou MA; Chapman MJ; Tselepis AD; Elisaf M
    J Lipid Res; 2002 Feb; 43(2):256-63. PubMed ID: 11861667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.
    Miwa M; Miyake T; Yamanaka T; Sugatani J; Suzuki Y; Sakata S; Araki Y; Matsumoto M
    J Clin Invest; 1988 Dec; 82(6):1983-91. PubMed ID: 3198761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
    Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Goudevenos JA; Chapman MJ; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):306-11. PubMed ID: 11834533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.
    Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Takamatsu S; Mizono S; Shoji B; Takamatsu M
    Prostaglandins; 1988 May; 35(5):685-98. PubMed ID: 3399678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
    Kulikov VI; Bergel'son LD
    Biokhimiia; 1984 Aug; 49(8):1310-5. PubMed ID: 6093897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke.
    Satoh K; Yoshida H; Imaizumi T; Takamatsu S; Mizuno S
    Stroke; 1992 Aug; 23(8):1090-2. PubMed ID: 1636183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor acetylhydrolase in human seminal plasma.
    Letendre ED; Miron P; Roberts KD; Langlais J
    Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
    J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions].
    Kawamura Y; Satoh K; Takamatsu S; Mizuno S
    Rinsho Byori; 1987 Oct; 35(10):1149-53. PubMed ID: 3437547
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
    Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
    J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
    Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
    J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mouse plasma PAF acetylhydrolase: II. It consists of two enzymes both associated with the HDL.
    Tsaoussis V; Vakirtzi-Lemonias C
    J Lipid Mediat Cell Signal; 1994 May; 9(3):317-31. PubMed ID: 7921790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
    De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
    Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
    J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.
    Elstad MR; Stafforini DM; McIntyre TM; Prescott SM; Zimmerman GA
    J Biol Chem; 1989 May; 264(15):8467-70. PubMed ID: 2722780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma].
    Kulikov VI; Muzia GI; Bergel'son LD
    Biokhimiia; 1984 Sep; 49(9):1449-55. PubMed ID: 6542803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
    Tsimihodimos V; Kakafika A; Tambaki AP; Bairaktari E; Chapman MJ; Elisaf M; Tselepis AD
    J Lipid Res; 2003 May; 44(5):927-34. PubMed ID: 12611907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
    Marathe GK; Zimmerman GA; McIntyre TM
    J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.